XML 17 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Assets    
Cash and cash equivalents $ 277,696 $ 282,914
Receivables 51,592 125,600
Real estate inventories 3,216,059 3,105,553
Investments in unconsolidated entities 5,410 5,870
Goodwill and other intangible assets, net 160,427 160,961
Deferred tax assets, net 67,768 76,413
Other assets 105,251 48,070
Total assets 3,884,203 3,805,381
Liabilities    
Accounts payable 81,313 72,870
Accrued expenses and other liabilities 335,149 330,882
Senior notes, net 1,410,804 1,471,302
Total liabilities 1,827,266 1,875,054
Commitments and contingencies
Stockholders’ Equity:    
Preferred stock, $0.01 par value, 50,000,000 shares authorized; no shares issued and outstanding as of December 31, 2018 and 2017, respectively 0 0
Common stock, $0.01 par value, 500,000,000 shares authorized; 141,661,713 and 151,162,999 shares issued and outstanding at December 31, 2018 and December 31, 2017, respectively 1,417 1,512
Additional paid-in capital 658,720 793,980
Retained earnings 1,396,787 1,134,230
Total stockholders’ equity 2,056,924 1,929,722
Noncontrolling interests 13 605
Total equity 2,056,937 1,930,327
Total liabilities and equity $ 3,884,203 $ 3,805,381